Page last updated: 2024-11-12

mefenoxam

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

metalaxyl-M : A methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate that is the more active R-enantiomer of metalaxyl. A systemic fungicide, it is active against phytopathogens of the order Peronosporales and is used to conrtrol Pythium in a number of vegetable crops. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11150163
CHEMBL ID1905521
CHEBI ID60607
SCHEMBL ID22529
MeSH IDM0448533

Synonyms (49)

Synonym
AC-16210
subdue maxx
metalaxyl-m [iso:bsi]
(-)-metalaxyl
ridomil gold
methenoxam
methyl n-(2,6-dimethylphenyl)-n-(methoxyacetyl)-d-alaninate
d-alanine, n-(2,6-dimethylphenyl)-n-(methoxyacetyl)-, methyl ester
methyl n-(methoxyacetyl)-n-(2,6-xylyl)-d-alaninate
mefenoxam
metalaxyl-m
NCGC00163907-01
C18626
CHEBI:60607 ,
methyl (r)-n-(2,6-dimethylphenyl)-n-(methoxyacetyl)alaninate
70630-17-0
methyl (r)-2-{[(2,6-dimethylphenyl)methoxyacetyl]amino} propionate
(r)-metalaxyl
r-metalaxyl
(r)-n-(2,6-dimethylphenyl)-n-(methoxyacetylamino)propionic acid methyl ester
unii-f1q54onn4h
f1q54onn4h ,
n-(2,6-dimethylphenyl)-n-(methoxyacetyl)-d-alanine methyl ester
AKOS015902582
SCHEMBL22529
CHEMBL1905521
d-(-)-metalaxyl
metalaxyl r-form [mi]
(-)-(r)-metalaxyl
d-alanine, n-(2,6-dimethylphenyl)-n-(2-methoxyacetyl)-, methyl ester
cga-329351
metalaxyl, (-)-
metalaxyl r-form
metalaxyl-m [iso]
tox21_303887
dtxsid8032671 ,
dtxcid6012671
NCGC00357145-01
cas-70630-17-0
metalaxyl-m, pestanal(r), analytical standard
metalaxyl-m 10 microg/ml in cyclohexane
(r)-methyl 2-(n-(2,6-dimethylphenyl)-2-methoxyacetamido)propanoate
Q27128142
ZQEIXNIJLIKNTD-GFCCVEGCSA-N
AMY22456
methyl (2r)-2-(n-(2-methoxyacetyl)-2,6-dimethylanilino)propanoate
methyl (2r)-2-[n-(2,6-dimethylphenyl)-2-methoxyacetamido]propanoate
CS-0128620
HY-B0843A

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Mefenoxam treatment of spinach seed provided complete protection against preemergence damping-off of spinach at both low (0.15 g a.i./kg of seed) and high (0.70 g a.i./kg of seed) rates of application, and the high rate of the application resulted in complete protection against web blight of spinach for 10 to 20 days after planting."( Characterization of Foliar Web Blight of Spinach, Caused by Pythium aphanidermatum, in the Desert Southwest of the United States.
Correll, JC; Feng, C; Liu, B; Matheron, ME, 2018
)
1.2

Toxicity

ExcerptReferenceRelevance
"Neonicotinoid residues can be present in soybean vegetative tissue, prey insects, and flower tissues, possibly making them toxic to pollinators and natural enemies."( Thiamethoxam Toxicity and Effects on Consumption Behavior in Orius insidiosus (Hemiptera: Anthocoridae) on Soybean.
Camargo, C; Giesler, LJ; Hunt, TE; Siegfried, BD, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninateAn alanine derivative that is methyl alaninate in which one of the hydrogens attached to the nitrogen is substituted by a methoxyacetyl group, while the other is substituted by a 2,6-dimethylphenyl group.
D-alanine derivativeA non-proteinogenic amino acid derivative resulting from reaction of D-alanine at the amino group or the carboxy group, or from the replacement of any hydrogen of D-alanine by a heteroatom.
acylamino acid fungicideAn amide fungicide whose structure contains an acylamino acid skeleton.
anilide fungicideAny amide fungicide whose structure contains an anilide group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency68.58960.001530.607315,848.9004AID1224841
pregnane X nuclear receptorHomo sapiens (human)Potency28.18380.005428.02631,258.9301AID720659
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency1.00000.001024.504861.6448AID588535
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (17.14)29.6817
2010's16 (45.71)24.3611
2020's13 (37.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.86 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index82.30 (26.88)
Search Engine Supply Index3.96 (0.95)

This Compound (32.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (2.50%)4.05%
Observational0 (0.00%)0.25%
Other39 (97.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]